To investigate whether vaginal isonicotinic acid hydrazide administered before intrauterine device (IUD) insertion reduces failed insertions, insertion-related complications and pain in in Women Delivered Only by Cesarean Delivery.
Women may experience pain and technical difficulties may be encountered when insertion of an intrauterine device is attempted through a narrow cervical canal. intrauterine device insertion- related complications and side effects are more common among women who had never delivered vaginally.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
220
3 vaginal tablet of isonicotinic acid hydrazide self inserted 12 hours before IUD insertion.
3 vaginal tablet of Placebo Comparator self inserted 12 hours before IUD insertion
Aswan University Hospital
Aswān, Egypt
the difference in the pain intensity scores between the study groups
the difference in the pain intensity scores between the study groups at IUD insertion BY10 cm visual analog scale score where 0 denotes no pain and 10 denotes the most imaginable pain
Time frame: 10 minutes
Provider ease of insertion
Provider ease of insertion was evaluated using a visual analog scale from 0 to 10 cm where 0 denotes very easy insertion and 10 denotes a very difficult insertion.
Time frame: 10 minutes
insertion time
IUD insertion time from speculum in to speculum out
Time frame: 10 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.